Capital Impact Advisors, LLC Madrigal Pharmaceuticals, Inc. Transaction History

Capital Impact Advisors, LLC

$3.16 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$171.37 - $283.23 $216,954 - $358,569	-1,266 Reduced 25.36%	3,726 $994,000
Q4 2023 Feb 14, 2024	BUY	$120.4 - $237.13 $343,501 - $676,531	2,853 Added 133.38%	4,992 $1.16 Million
Q2 2023 Aug 14, 2023	SELL	$203.88 - $312.0 $153,521 - $234,936	-753 Reduced 26.04%	2,139 $494,000
Q1 2023 May 23, 2023	BUY	$231.06 - $307.08 $101,204 - $134,501	438 Added 17.85%	2,892 $700,000
Q4 2022 Feb 14, 2023	SELL	$58.39 - $296.54 $333,290 - $1.69 Million	-5,708 Reduced 69.93%	2,454 $712,000
Q2 2022 Aug 15, 2022	SELL	$58.04 - $100.2 $255,027 - $440,278	-4,394 Reduced 35.0%	8,162 $584,000
Q1 2022 May 16, 2022	SELL	$55.89 - $101.89 $318,181 - $580,059	-5,693 Reduced 31.2%	12,556 $1.23 Million
Q4 2021 Feb 14, 2022	BUY	$72.34 - $95.09 $468,329 - $615,612	6,474 Added 54.98%	18,249 $1.55 Million
Q2 2021 Aug 17, 2021	SELL	$97.2 - $137.59 $2.07 Million - $2.93 Million	-21,273 Reduced 64.37%	11,775 $1.15 Million
Q1 2021 May 18, 2021	BUY	$108.54 - $125.2 $943,972 - $1.09 Million	8,697 Added 35.72%	33,048 $3.87 Million
Q4 2020 Feb 12, 2021	BUY	$110.06 - $133.7 $2.68 Million - $3.26 Million	24,351 New	24,351 $2.71 Million
Q3 2020 Nov 13, 2020	SELL	$99.78 - $124.21 $2.43 Million - $3.02 Million	-24,351 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$66.76 - $93.49 $66,492 - $93,116	996 Added 4.26%	24,351 $1.63 Million
Q4 2019 Feb 13, 2020	BUY	$84.28 - $118.5 $232,781 - $327,297	2,762 Added 13.41%	23,355 $2.13 Million
Q3 2019 Nov 14, 2019	BUY	$84.4 - $106.53 $206,358 - $260,465	2,445 Added 13.47%	20,593 $1.75 Million
Q2 2019 Jul 19, 2019	BUY	$91.13 - $142.5 $409,082 - $639,682	4,489 Added 32.86%	18,148 $1.82 Million
Q4 2018 Mar 08, 2019	BUY	$94.77 - $215.54 $612,024 - $1.39 Million	6,458 Added 89.68%	13,659 $1.43 Million
Q3 2018 Oct 19, 2018	BUY	$207.3 - $300.31 $123,550 - $178,984	596 Added 9.02%	7,201 $1.53 Million
Q2 2018 Jul 25, 2018	SELL	$101.55 - $313.9 $466,114 - $1.44 Million	-4,590 Reduced 41.0%	6,605 $1.84 Million
Q1 2018 Apr 11, 2018	BUY	$93.35 - $149.04 $1.05 Million - $1.67 Million	11,195 New	11,195 $1.31 Million

Others Institutions Holding MDGL

# of Institutions

296

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

Janus Henderson Group PLC London, X0

2.48M
Shares

$861 Million
0.28% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

2.04M
Shares

$709 Million
29.57% of portfolio
Avoro Capital Advisors LLC New York, NY

2.03M
Shares

$705 Million
6.48% of portfolio
Rtw Investments, LP New York, NY

1.99M
Shares

$693 Million
6.74% of portfolio
Baker Bros. Advisors LP New York, NY

1.97M
Shares

$686 Million
4.49% of portfolio

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.94B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Impact Advisors, LLC with notifications on news.

Account